We are live on ! Find out more
INO icon

Inovio Pharmaceuticals
INO

125 hedge funds and large institutions have $184M invested in Inovio Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 17 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

224% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 17

90% more call options, than puts

Call options by funds: $2.27M | Put options by funds: $1.2M

57% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 14

6% more funds holding

Funds holding: 118 → 125 (+7)

5% more capital invested

Capital invested by funds: $176M → $184M (+$8.52M)

0.18% more ownership

Funds ownership: 2.5% → 2.69% (+0.18%)

Holders
125
Holders Change
+7
Holders Change %
+5.93%
% of All Funds
3.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
55
Reduced
17
Closed
14
Calls
$2.27M
Puts
$1.2M
Net Calls
+$1.07M
Net Calls Change
+$30K

Top Buyers

1
State Street
State Street
Massachusetts
+$9.86M
2
BlackRock
BlackRock
New York
+$7.55M
3
Citadel Advisors
Citadel Advisors
Florida
+$3.67M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$3.43M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.27M

Top Sellers

1
CS
Candriam SCA
Luxembourg
-$744K
2
TCM
Tanaka Capital Management
New York
-$688K
3
ARTA
A.R.T. Advisors
New York
-$618K
4
Goldman Sachs
Goldman Sachs
New York
-$582K
5
PAM
Panagora Asset Management
Massachusetts
-$326K
Name Holding Trade Value Shares
Change 		Change in
Stake
Tudor Investment Corp
51
Tudor Investment Corp
Connecticut
$317K +$310K +4,167 New
California Public Employees Retirement System
52
California Public Employees Retirement System
California
$316K – – –
VF
53
Virtu Financial
New York
$303K +$296K +3,984 New
NFA
54
Nationwide Fund Advisors
Ohio
$281K +$35.3K +474 +15%
KeyBank National Association
55
KeyBank National Association
Ohio
$271K +$78K +1,048 +42%
VEA
56
Virtus ETF Advisers
New York
$261K +$23.4K +314 +10%
VOYA Investment Management
57
VOYA Investment Management
Georgia
$228K +$28.1K +377 +14%
DekaBank Deutsche Girozentrale
58
DekaBank Deutsche Girozentrale
Germany
$226K – – –
PCM
59
Piermont Capital Management
Missouri
$216K +$212K +2,843 New
Bank of America
60
Bank of America
North Carolina
$207K +$111K +1,495 +122%
ARTA
61
A.R.T. Advisors
New York
$183K -$618K -8,308 -77%
EMG
62
Ellington Management Group
Connecticut
$178K +$36.6K +492 +27%
State Board of Administration of Florida Retirement System
63
State Board of Administration of Florida Retirement System
Florida
$169K – – –
UBS AM
64
UBS AM
Illinois
$168K +$5.06K +68 +3%
PNC Financial Services Group
65
PNC Financial Services Group
Pennsylvania
$154K +$19.9K +267 +15%
FIB
66
First Interstate Bank
Montana
$154K +$112K +1,508 +292%
BAM
67
Belpointe Asset Management
Nevada
$150K +$147K +1,970 New
Northwestern Mutual Wealth Management
68
Northwestern Mutual Wealth Management
Wisconsin
$138K – – –
ZIM
69
Zacks Investment Management
Illinois
$137K +$134K +1,806 New
Barclays
70
Barclays
United Kingdom
$134K +$1.41K +19 +1%
Legal & General Group
71
Legal & General Group
United Kingdom
$132K +$29.6K +398 +30%
EA
72
Emerald Advisers
Pennsylvania
$129K +$57.6K +774 +84%
Russell Investments Group
73
Russell Investments Group
United Kingdom
$119K -$255K -3,432 -69%
EGM
74
Engineers Gate Manager
New York
$117K +$115K +1,542 New
Neuberger Berman Group
75
Neuberger Berman Group
New York
$115K +$113K +1,514 New
1 2
3
4 5

INO Hedge Fund Activity: Q3 2017 in Review

125 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Inovio Pharmaceuticals (INO) for Q3 2017, worth a combined $184M — up 4.8% from $176M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new INO positions and 14 closed out — a net gain of 8 holders — while 55 added to existing stakes and 17 trimmed.

The largest buyer was State Street, adding an estimated $9.86M. The largest seller was Candriam SCA, cutting an estimated $744K.

  • 125 institutional investors held Inovio Pharmaceuticals (INO) as of Q3 2017, up from 118 in Q2 2017.
  • Funds reported $184M of Inovio Pharmaceuticals stock for Q3 2017, up 4.8% quarter-over-quarter.
  • 22 funds opened new Inovio Pharmaceuticals positions in Q3 2017 and 14 closed out, a net change of +8 holders.
  • The largest Inovio Pharmaceuticals buyer in Q3 2017 was State Street, an estimated $9.86M added.
  • The largest Inovio Pharmaceuticals seller in Q3 2017 was Candriam SCA, an estimated $744K sold.

Based on aggregated 13F filings for Q3 2017.